Dermatology and Therapy

OCT 7, 2026 · JOURNAL ARTICLE

Topical Delgocitinib for Capecitabine-Induced Hand–Foot Syndrome: A Therapeutic Option?

Dermatology and Therapy

Hand–foot syndrome (HFS) is a frequent and potentially dose-limiting adverse event of capecitabine. Current therapeutic strategies are not always effective. Since inflammatory path

OCT 6, 2026 · JOURNAL ARTICLE

Canadian Expert Consensus Recommendations on the Use of Photodynamic Therapy in Actinic Keratosis

Dermatology and Therapy

Actinic keratosis (AK), a common ultraviolet light-induced keratinocyte neoplasm arising within chronically photodamaged skin, is associated with field cancerization and potential

OCT 2, 2026 · JOURNAL ARTICLE

Baricitinib Efficacy Through 4 Years in Responders and Safety up to 5 Years in Adults with Severe Alopecia Areata: Final Results from BRAVE-AA1 and BRAVE-AA2

Dermatology and Therapy

Long-term efficacy and safety data are imperative for therapies used to treat severe alopecia areata (AA) because the disease is chronic, loss of response can be devastating to pat

AUG 11, 2026 · JOURNAL ARTICLE

Skin Impacts and Tradeoffs of GLP-1 Therapy: Improved Patient-Reported Outcomes of Inflammatory Skin Disease in the Era of “Ozempic Face”

Dermatology and Therapy

Large voluntary survey with patient-reported outcomes showing dermatologic effects associated with GLP-1RA weight loss, but lacks a controlled comparator group and relies on unvalidated self-report without clinical adjudication.